COMMUNIQUÉS West-GlobeNewswire

Albireo Receives FDA Fast Track Designation for A4250
17/10/2018
BOSTON, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the U.S. Food and Drug [...]
MedTainer Capturing Larger Share of Canadian Cannabis Market
17/10/2018
CORONA, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- MedTainer™ Inc. ( MDTR-OTCMARKETS ) announced today that they are capturing a larger-than-expected share of the Canadian cannabis packaging market. In the course of the [...]
Onconova Therapeutics Announces Issuance of a New U.S. Patent for Rigosertib
17/10/2018
Granted claims cover both oral and injectable formulations of Rigosertib Newly issued US patent 10,098,862 extends protection for Rigosertib into 2037 Equivalent coverage is being sought worldwide and, if granted, will [...]
Todos Medical, Ltd. Announces Additional Patent Issuance Covering the Use of IR Spectrum of Blood Plasma For Indicating the Presence of Breast Cancer
17/10/2018
REHOVOT, Israel, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Todos Medical, Ltd. Inc. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer, [...]
BrainStorm to Announce Third Quarter Financial Results and Provide Corporate Update on Monday, October 29
17/10/2018
Conference Call and Live Webcast at 8:30am Eastern Time NEW YORK and PETACH TIKVAH, Israel, Oct. 17, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell [...]
Nutritional High and Aura Health Announce Partnership to Develop International Markets
17/10/2018
TORONTO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Nutritional High International Inc. (" Nutritional High ") (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) and Aura Health Inc. (“ Aura ”) ( CSE: BUZZ ) are pleased to announce the [...]
New Jersey Dentist Opens New Office Location in Green Brook
17/10/2018
Dr. John D. Beckwith has expanded his private practice, Cornerstone Dental, with a second office location in Green Brook, New Jersey. HILLSBOROUGH, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Cornerstone Dental is an all- [...]
Achaogen Submits Marketing Authorization Application to the European Medicines Agency for Plazomicin
17/10/2018
-- MAA submission for complicated urinary tract infections (cUTI), bloodstream infections, and infections due to Enterobacteriaceae in adult patients with limited treatment options -- SOUTH SAN FRANCISCO, Calif., Oct. [...]
Inovio’s DNA-Encoded Monoclonal Antibody (dMAb™) Platform Moves Ahead with Positive Data, Patents and Grants
17/10/2018
Two new U.S. Patents for Inovio’s dMAb technology were issued Inovio awarded new $2.2 million Gates Foundation grant to support dMAb development and next-generation dMAb delivery clinical device PLYMOUTH MEETING, Pa., [...]
Sirona Biochem Engages Consultant for Japanese Market Penetration
17/10/2018
VANCOUVER, British Columbia , Oct. 17, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (Xetra: ZSB) (the “ Company ”) is pleased to announce that it has engaged Mr. Sven Harpering, a Tokyo-based [...]
ORYZON receives approval to start CLEPSIDRA: a Phase IIa clinical trial in Small Cell Lung Cancer with Iadademstat (ORY-1001)
17/10/2018
The study will be done in SCLC patients in combination with Platinum-Etoposide chemotherapy MADRID, Spain and CAMBRIDGE, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Oryzon Genomics S.A. (ISIN Code: ES0167733015, ORY), (“ [...]
Assertio Therapeutics to Participate in Upcoming Investor Conferences
17/10/2018
LAKE FOREST, Ill., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, today announced that members of senior [...]
BioStem Technologies Selects PCG Advisory Group for Investor Relations and Strategic Communications
17/10/2018
Pompano Beach, FL, Oct. 17, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation providing innovative technologies with a concentration in [...]
Cue Biopharma Announces Strategic Research Collaboration with Albert Einstein College of Medicine to Further the Potential of Immuno-STAT™ Platform in Chronic Infectious Diseases
17/10/2018
Collaboration Expands Platform’s Reach Beyond Cancer and Autoimmune Disease to Address T cell Exhaustion in Chronic Infectious Diseases CAMBRIDGE, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: [...]
BrainsWay to Showcase Deep Transcranial Magnetic Stimulation System for the Treatment of Obsessive-Compulsive Disorder at the 2018 Annual Psych Congress
17/10/2018
Showcase represents the public debut of BrainsWay’s Deep TMS system for OCD Healthcare providers will be able to view demonstrations of and purchase the BrainsWay system and OCD helmet at conference booth #109 [...]
CareDx to Announce Third Quarter 2018 Financial Results on November 8, 2018
17/10/2018
BRISBANE, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
Intra-Cellular Therapies Presents Results from ITI-214 Phase 1/2 Clinical Trial in Patients with Parkinson’s Disease at 2018 American Neurological Association Annual Meeting
17/10/2018
NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
IntelGenx Receives Over $1.6 Million from Exercise of Warrants
17/10/2018
SAINT LAURENT, Quebec, Oct. 17, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) is pleased to announce that, since September 15, 2018, it has received [...]
Clinical Laserthermia Systems (CLS) Signs Exclusive Distribution Agreement with MRI Interventions for USA and Canada
17/10/2018
2-Year Agreement Enables MRI Interventions to Distribute CLS’s Precision Ablation Product Portfolio for Use in Interventional MR-Guided Procedures Beyond their Previously Announced Spine and Neuro License Agreement [...]

Pages